WARMINSTER, Pa., Feb. 27, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its fourth quarter and Year-End 2019 financial… Read More
SEATTLE, Feb. 25, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. (“Neoleukin”) (Nasdaq: NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the appointment of Robert Ho as Chief Financial Officer, effective March… Read More
SEATTLE, Feb. 24, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. (“Neoleukin”) (Nasdaq: NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that Jonathan Drachman, M.D., Chief Executive Officer, will present… Read More
Anterra Capital leads financing to advance Invetx’s pipeline of animal biologic drugs leveraging breakthroughs in human biopharma Global biologics CDMO WuXi Biologics makes equity investment and joins as R&D collaborator… Read More
SAN DIEGO, CA, Feb. 19, 2020 (GLOBE NEWSWIRE) — Emerald Health Pharmaceuticals Inc. (EHP), a clinical-stage pharmaceutical company developing medicines based on cannabinoid science, has been accepted to make two… Read More
